Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (31-40 of 272) with videos related to

Pageof 28
Sort By:
Neuroinformatics|December 23, 2017
Multi-Table Differential Correlation Analysis of Neuroanatomical and Cognitive Interactions in Turner SyndromeChristof Seiler, Tamar Green, David Hong, et al.
American Journal of Hematology|May 14, 2009
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experienceSushma Vemulapalli, Lakshmi Chintala, Apostolia-Maria Tsimberidou, et al.
Oncotarget|January 8, 2014
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphomaVivek Subbiah, Robert E Brown, Mary F McGuire, et al.
Journal of Medical Internet Research|August 18, 2021
Content and Communication of Inpatient Family Visitation Policies During the COVID-19 Pandemic: Sequential Mixed Methods StudyJoanna Hart, Amy Summer, Kuldeep N Yadav, et al.
Gynecologic Oncology|October 28, 2018
Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trialsEmily Hinchcliff, David Hong, Hung Le, et al.
Molecular Cancer Therapeutics|May 1, 2008
Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnibDavid Hong, Lei Ye, Robert Gagel, et al.
Revista Espanola De Cardiologia (English Ed.)|December 13, 2025
Angiotensin receptor blocker versus angiotensin receptor-neprilysin inhibitor in improved HF with stabilized NT-proBNP levelsMinjung Bak, Yoonjee Park, Darae Kim, et al.
Chemosphere|September 22, 2020
Synthesis, insecticidal activity, resistance, photodegradation and toxicity of pyrethroids (A review)Qiuyan Zhu, Yang Yang, Yingying Zhong, et al.
Scientific Reports|December 27, 2024
Discontinuation rates, clinical effects and provocation factors of SGLT-2 inhibitor in the real worldMinjung Bak, Sang Ah Chi, Kina Jeon, et al.
Veterinary Parasitology|March 4, 2020
Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?Joseph D Turner, Amy E Marriott, David Hong, et al.
Pageof 28

Showing results (31-40 of 272) with videos related to

Sort By:
Pageof 28
Neuroinformatics|December 23, 2017
Multi-Table Differential Correlation Analysis of Neuroanatomical and Cognitive Interactions in Turner SyndromeChristof Seiler, Tamar Green, David Hong, et al.
American Journal of Hematology|May 14, 2009
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experienceSushma Vemulapalli, Lakshmi Chintala, Apostolia-Maria Tsimberidou, et al.
Oncotarget|January 8, 2014
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphomaVivek Subbiah, Robert E Brown, Mary F McGuire, et al.
Journal of Medical Internet Research|August 18, 2021
Content and Communication of Inpatient Family Visitation Policies During the COVID-19 Pandemic: Sequential Mixed Methods StudyJoanna Hart, Amy Summer, Kuldeep N Yadav, et al.
Gynecologic Oncology|October 28, 2018
Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trialsEmily Hinchcliff, David Hong, Hung Le, et al.
Molecular Cancer Therapeutics|May 1, 2008
Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnibDavid Hong, Lei Ye, Robert Gagel, et al.
Revista Espanola De Cardiologia (English Ed.)|December 13, 2025
Angiotensin receptor blocker versus angiotensin receptor-neprilysin inhibitor in improved HF with stabilized NT-proBNP levelsMinjung Bak, Yoonjee Park, Darae Kim, et al.
Chemosphere|September 22, 2020
Synthesis, insecticidal activity, resistance, photodegradation and toxicity of pyrethroids (A review)Qiuyan Zhu, Yang Yang, Yingying Zhong, et al.
Scientific Reports|December 27, 2024
Discontinuation rates, clinical effects and provocation factors of SGLT-2 inhibitor in the real worldMinjung Bak, Sang Ah Chi, Kina Jeon, et al.
Veterinary Parasitology|March 4, 2020
Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?Joseph D Turner, Amy E Marriott, David Hong, et al.
Pageof 28